This inventor holds 1 USPTO granted patent and 5 published patent applications and 3 EPO patents. Top assignee: Csl Behring Gmbh. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Christine Voigt: Innovator in Hematopoietic Cell Transplantation
Introduction
Christine Voigt is a notable inventor based in Devon, PA (US). She has made significant contributions to the field of hematopoietic cell transplantation, particularly in the prevention of graft versus host disease (GVHD). Her innovative methods have the potential to improve patient outcomes in this critical area of medicine.
Latest Patents
Christine Voigt holds 1 patent for her work titled "Methods for reducing risk of onset of acute graft versus host disease after hematopoietic cell transplantation." This patent focuses on methods for preventing or reducing the risk of GVHD in patients undergoing hematopoietic cell transplantation by administering alpha-1 antitrypsin (A1AT) both before and after the procedure. Additionally, it outlines specific treatment methods for acute GVHD using A1AT.
Career Highlights
Throughout her career, Christine has worked with prominent companies in the biopharmaceutical industry, including CSL Behring GmbH and CSL Behring Lengnau AG. Her experience in these organizations has allowed her to develop and refine her innovative approaches to patient care.
Collaborations
Christine has collaborated with esteemed colleagues such as Gautam Baheti and John Roberts. These partnerships have contributed to her success and the advancement of her research in the field.
Conclusion
Christine Voigt is a pioneering inventor whose work in hematopoietic cell transplantation is making a significant impact on patient care. Her innovative methods and collaborations highlight her dedication to improving medical outcomes for patients facing serious health challenges.